Skip to main content
logo
Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
18.22
+0.10 (0.55%)
At close: Oct 24, 2025, 4:00 PM EDT
17.95
-0.27 (-1.48%)
After-hours: Oct 24, 2025, 7:11 PM EDT

Roivant Sciences Revenue

Roivant Sciences had revenue of $2.17M in the quarter ending June 30, 2025, a decrease of -72.84%. This brings the company's revenue in the last twelve months to $23.23M, down -35.86% year-over-year. In the fiscal year ending March 31, 2025, Roivant Sciences had annual revenue of $29.05M, down -11.19%.

Revenue (ttm)
$23.23M
Revenue Growth
-35.86%
P/S Ratio
541.82
Revenue / Employee
$30,977
Employees
750
Market Cap
12.59B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202529.05M-3.66M-11.19%
Mar 31, 202432.71M1.18M3.75%
Mar 31, 202331.53M-23.76M-42.97%
Mar 31, 202255.29M31.49M132.34%
Mar 31, 202123.80M-43.89M-64.85%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

ROIV News

More News